Table 3-3 Pretreatment condition 3.
a. Total | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diagnostic imaging | Sites of occlusion | TASC II classification aortoiliac | TASC II classification femoropopliteal | |||||||||||||
IADSA | CTA | Others | Aortoiliac | Femoropop | Lower leg/foot | A | B | C | D | No lesion | A | B | C | D | No lesion | |
Rutherford 4 | 165 | 121 | 18 | 79 | 161 | 105 | 20 | 8 | 6 | 36 | 3 | 19 | 35 | 24 | 106 | 13 |
Rutherford 5 | 531 | 328 | 28 | 137 | 435 | 489 | 44 | 28 | 15 | 49 | 0 | 112 | 103 | 94 | 244 | 107 |
Rutherford 6 | 136 | 51 | 11 | 41 | 81 | 113 | 11 | 13 | 5 | 9 | 1 | 15 | 10 | 13 | 67 | 37 |
Total | 832 | 500 | 57 | 257 | 677 | 707 | 75 | 49 | 26 | 94 | 4 | 146 | 148 | 131 | 417 | 157 |
b. ASO | ||||||||||||||||
Diagnostic imaging | Sites of occlusion | TASC II classification aortoiliac | TASC II classification femoropopliteal | |||||||||||||
IADSA | CTA | Others | Aortoiliac | Femoropop | Lower leg/foot | A | B | C | D | No lesion | A | B | C | D | No lesion | |
Rutherford 4 | 162 | 118 | 18 | 79 | 158 | 100 | 20 | 8 | 6 | 36 | 3 | 19 | 35 | 24 | 101 | 13 |
Rutherford 5 | 517 | 323 | 26 | 134 | 429 | 475 | 44 | 27 | 15 | 47 | 0 | 112 | 103 | 92 | 237 | 101 |
Rutherford 6 | 134 | 50 | 11 | 41 | 80 | 111 | 11 | 13 | 5 | 9 | 1 | 15 | 10 | 13 | 65 | 37 |
Total | 813 | 491 | 55 | 254 | 667 | 686 | 75 | 48 | 26 | 92 | 4 | 146 | 148 | 129 | 403 | 151 |
IADSA: intra-arterial digital subtraction angiography, CTA: computed tomography angiography